---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007448"
form_type: "8-K"
ticker: "GRCE"
cik: "0001444192"
company_name: "Grace Therapeutics, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:21:39.172381+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Acasti voluntarily delists from TSX Venture; confirms no SVB/Silvergate exposure

## Summary
- Voluntary delisting from TSXV effective March 27, 2023; Nasdaq listing under ACST unaffected.
- Company cites low TSXV volume and high dual-listing costs; expects central Nasdaq marketplace to aid liquidity.
- Confirms no exposure to Silicon Valley Bank or Silvergate Bank; no deposits held at those institutions.

## SEC filing metadata
- accession: 0000950170-23-007448
- form_type: 8-K
- ticker: GRCE
- cik: 0001444192
- company_name: Grace Therapeutics, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1444192/000095017023007448/0000950170-23-007448-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1444192/000095017023007448/acst-20230313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007448
- JSON: https://secwatch.observer/filing/0000950170-23-007448.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007448.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.